Increasing overheads linked to high value biologics and personalized medicines, highly variable patient enrollmenT and the constant need to reduce timelines and capacity for waste caused by expensive, time sensitive drugs and limited availability can combine to create a perfect storm for sponsors of early phase clinical trials.

Explore five of the key ways JTM can improve your early phase clinical supply chain:

1. Ease the forecasting headache
2. Reduce waste of expensive IMP
3. Increase control over expiry date assignment
4. To improve patient centricity
5. To expedite key study milestones

Download our latest guide to discover why Just in Time Manufacturing (JTM) has the potential to add significant value to early phase trials, through its ability to respond quickly to shifting demand, while preserving drug product.